OCCUPATION: Founder, Institute for OneWorld Health
NUMBER OF TIME COVERS: 0
PREVIOUS APPEARANCES ON THE TIME 100: 0
PRO: Hale's non-profit firm is developing drugs and vaccines against diseases of the developing world, like malaria and Chagas disease. OneWorld has already brought to market a drug for visceral leishmaniasis, a disease that sickens 1.5 million people in Asia and Africa.
CON: OneWorld's model, while commendable, does little to address the unaffordable cost of drugs for hundreds of other common diseases.
Next MATT GROENING